Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Health Data Research UK

- PMLiVE

EFPIA pledges to boost drug access throughout Europe

Transformative proposals from the research-based pharma industry should reduce inequalities in patient access to medicines across Europe

- PMLiVE

Total COVID-19 vaccine spending to reach $157bn by 2025, says report

Report also forecasts total global medicines spending to hit approximately $1.6 trillion in 2025

- PMLiVE

The flexible salesforce

By John Procter

- PMLiVE

Growing up as a patient is hard to manage

By Clare Moloney

- PMLiVE

IQVIA and partners set up cancer ‘data hub’ to speed up research

Seven research centres to be rolled out across UK

- PMLiVE

IQVIA launches new online patient portal

Seeks to improve clinical trial experience

- PMLiVE

Biotech now vital to pipelines – but success rates falling

IQVIA picks out key trends to drive future productivity

- PMLiVE

IQVIA sees market slowdown looming for pharma

Growth rates dip below the 6% average

- PMLiVE

UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Invests in Genomics England alliance, plus clinical trials expansion

- PMLiVE

New models of NHS care – new models of pharma response?

At PME and IQVIA’s roundtable event, leaders discuss how industry needs to adapt to help an NHS undergoing transformational change

Pharma: in search of the sustainable ‘win win’ with the NHS

Fiona Bride on how Novartis is responding to new models of care

- PMLiVE

Brexit rebels win vote on European Medicines Agency alignment

EMA membership will be a key negotiating aim; Sir John Bell sees independent MHRA post-Brexit

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links